Literature DB >> 24594230

Long term results of childhood dysphonia treatment.

Hanna Mackiewicz-Nartowicz1, Anna Sinkiewicz1, Arleta Bielecka1, Hanna Owczarzak1, Magdalena Mackiewicz-Milewska2, Piotr Winiarski3.   

Abstract

OBJECTIVE: The aim of this study was to assess the long term results of treatment and rehabilitation of childhood dysphonia.
METHODS: This study included a group of adolescents (n=29) aged from 15 to 20 who were treated due to pediatric hyperfunctional dysphonia and soft vocal fold nodules during their pre-mutational period (i.e. between 5 and 12 years of age). The pre-mutational therapy was comprised of proper breathing pattern training, voice exercises and psychological counseling. Laryngostroboscopic examination and perceptual analysis of voice were performed in each patient before treatment and one to four years after mutation was complete. The laryngostroboscopic findings, i.e. symmetry, amplitude, mucosal wave and vocal fold closure, were graded with NAPZ scale, and the GRBAS scale was used for the perceptual voice analysis.
RESULTS: Complete regression of the childhood dysphonia was observed in all male patients (n=14). Voice disorders regressed completely also in 8 out of 15 girls, but symptoms of dysphonia documented on perceptual scale persisted in the remaining seven patients.
CONCLUSIONS: Complex voice therapy implemented in adolescence should be considered as either the treatment or preventive measure of persistent voice strain, especially in girls.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Childhood dysphonia; Laryngovideostroboscopy; Vocal fold nodules; Voice therapy

Mesh:

Year:  2014        PMID: 24594230     DOI: 10.1016/j.ijporl.2014.02.002

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  1 in total

1.  Cut-off point for high dysphonia risk in children based on the Child Dysphonia Risk Screening Protocol: preliminary findings.

Authors:  Giovana Kaila Santos Batista; Marcia Simões-Zenari; Kátia Nemr
Journal:  Clinics (Sao Paulo)       Date:  2020-08-26       Impact factor: 2.365

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.